Ovarian cancer, oral contraceptives, and BRCA mutations
Narod, S.A.; Sun, P.; Risch, H.A.
New England Journal of Medicine 345(23): 1706-1707
2001
ISSN/ISBN: 0028-4793 PMID: 11759652 DOI: 10.1056/nejm200112063452312Document Number: 244755
Document emailed within 0-6 h
Related Documents
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329Milsom, I.; Odlind, V. 2008: Oral contraceptives give long-lasting protection against ovarian cancer. use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden Lakartidningen 105(10): 715-716
Ben David, Y.; Chetrit, A.; Hirsh-Yechezkel, G.; Friedman, E.; Beck, B.D.; Beller, U.; Ben-Baruch, G.; Fishman, A.; Levavi, H.; Lubin, F.; Menczer, J.; Piura, B.; Struewing, J.P.; Modan, B. 2002: Effect of BRCA mutations on the length of survival in epithelial ovarian tumors Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 463-466
1989: Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Epidemiology 18(3): 538-545
1989: Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Epidemiology 18(3): 538-545
Olmos, D.; Castro, E. 2013: BRCA mutations in prostate cancer patients Clinical Advances in Hematology and Oncology: H&o 11(9): 598-599
Grann, V. 1997: Risk of breast cancer in carriers of BRCA gene mutations New England Journal of Medicine 337(11): 788
Rosenblatt, K.A.; Thomas, D.B.; Noonan, E.A. 1992: High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives European Journal of Cancer 28a (11): 1872-1876
Rosenblatt, K.A.; Thomas, D.B.; Noonan, E.A. 1992: High-dose and low-dose combined oral contraceptives: protection against epithelial ovarian cancer and the length of the protective effect. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives European Journal of Cancer 28a (11): 1872-1876
Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Bosetti, C.; Negri, E.; Trichopoulos, D.; Franceschi, S.; Beral, V.; Tzonou, A.; Parazzini, F.; Greggi, S.; La Vecchia, C. 2002: Long-term effects of oral contraceptives on ovarian cancer risk International Journal of Cancer 102(3): 262-265
Liu, M.; Luo, Z.; Yue, Y. 1992: Epidemiologic study of the effect of oral contraceptives on reducing the incidence of ovarian cancer Zhonghua Yi Xue Za Zhi 72(2): 124-125
Schildkraut, J.M.; Calingaert, B.; Marchbanks, P.A.; Moorman, P.G.; Rodriguez, G.C. 2002: Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk Journal of the National Cancer Institute 94(1): 32-38
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives : levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception (Stoneham) 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292